id	sid	eid	entity	type
ffhd-1396	1	1	japanese	NORP
ffhd-1396	1	2	2160-3855	CARDINAL
ffhd-1396	1	3	issn	PERSON
ffhd-1396	1	4	2378-7007	DATE
ffhd-1396	1	5	2160-3855	CARDINAL
ffhd-1396	1	6	issn	PERSON
ffhd-1396	1	7	2378-7007	DATE
ffhd-1396	2	1	14	CARDINAL
ffhd-1396	2	2	2024): july 2024	DATE
ffhd-1396	2	3	japanese	NORP
ffhd-1396	2	4	lee yoshitaka	PERSON
ffhd-1396	2	5	kuwabara akiko hirose yuji makino kyohei	PERSON
ffhd-1396	2	6	sakata tadashi watanabe doi:	PERSON
ffhd-1396	2	7	https://doi.org/10.31989/ffhd.v14i7.1396	CARDINAL
ffhd-1396	4	1	85.2-fold	CARDINAL
ffhd-1396	5	1	japanese	NORP
ffhd-1396	7	1	ninety	CARDINAL
ffhd-1396	7	2	japanese	NORP
ffhd-1396	7	3	150 mg	QUANTITY
ffhd-1396	7	4	12 weeks	DATE
ffhd-1396	8	1	every 4 weeks	DATE
ffhd-1396	10	1	week 12	DATE
ffhd-1396	12	1	150mg	QUANTITY
ffhd-1396	13	1	theracurmin	ORG
ffhd-1396	15	1	2024	CARDINAL
ffhd-1396	16	1	14	CARDINAL
ffhd-1396	16	2	2024): july 2024	DATE
ffhd-1396	16	3	2024	CARDINAL
ffhd-1396	16	4	4.0	CARDINAL
ffhd-1396	17	1	ffc	ORG
ffhd-1396	17	2	first	ORDINAL
ffhd-1396	17	3	4.0	CARDINAL